34 results on '"Mohiuddin, Muhammad"'
Search Results
2. The road to the first FDA‐approved genetically engineered pig heart transplantation into human
3. Progressive genetic modifications of porcine cardiac xenografts extend survival to 9 months
4. An intrinsic link to an extrinsic cause of cardiac xenograft growth after xenotransplantation
5. Early graft failure of GalTKO pig organs in baboons is reduced by expression of a human complement pathway-regulatory protein
6. Role of anti-CD40 antibody-mediated costimulation blockade on non-Gal antibody production and heterotopic cardiac xenograft survival in a GTKO.hCD46Tg pig-to-baboon model
7. Recent progress and remaining hurdles toward clinical xenotransplantation
8. Ex-vivo expanded baboon CD4+ CD25Hi Treg cells suppress baboon anti-pig T and B cell immune response
9. Combined telemetry and video monitoring offers the most accurate assessment of transplanted xenograft function and recipient baboons health status: 519
10. Early graft function of heterotopic cardiac xenografts: lessons learned from a large animal cardiac xenotransplantation program: 518
11. Absence of thrombotic complication is a major advantage of murine anti CD40 over anti CD154 in heterotopic cardiac xenotransplantation studies: 509
12. Rituxan and co stimulation blockade based immunosuppression effectively prevents pig cardiac xenograft rejection in baboon for up to 8 months: 339
13. Induction B-cell depletion, but not CD28/B7-directed costimulation blockade, prevents induced anti-non-Gal antibody responses after GalTKO.hCD46 cardiac xenotransplantation: 323
14. Long-term cardiac xenograft (pig to baboon) survival is correlated with presence of increased percentage of CD4+CD25HiFoxP3+ T regulatory cells: 320
15. Induced T regulatory (iTreg) cells suppress T and B cell immune responses: 129
16. Rapamycin enriches CD4 + CD25 hi T regulatory cells in ex-vivo expanded CD4 T cells in baboon: 308.6
17. Characterization and expansion of baboon CD4+CD25+ Treg cells for potential use in a non-human primate xenotransplantation model
18. ThirdWHOGlobal Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials, Changsha, Hunan, China December 12–14, 2018
19. Cover Image, Volume 26, Issue 2
20. Improved experimental cardiac xenograft survival with cyclophosphamide and intrathymic donor cells
21. Cardiac xenografts show reduced survival in the absence of transgenic human thrombomodulin expression in donor pigs
22. CD4+CD25Hi FoxP3+ regulatory T cells in long-term cardiac xenotransplantation
23. JOINT FDA-IXA SYMPOSIUM, SEPTEMBER 20, 2017
24. Encouraging experience using multi-transgenic xenografts in a pig-to-baboon cardiac xenotransplantation model
25. CD4+CD25HiFoxP3+ regulatory T cells in long‐term cardiac xenotransplantation.
26. Miscellaneous.
27. Role of anti-CD40 antibody-mediated costimulation blockade on non-Gal antibody production and heterotopic cardiac xenograft survival in a GTKO.hCD46Tg pig-to-baboon model
28. Characterization and expansion of baboon CD4+CD25+Treg cells for potential use in a non-human primate xenotransplantation model
29. Ex-vivo expanded baboon CD4+ CD25Hi Treg cells suppress baboon anti-pig T and B cell immune response.
30. Characterization and expansion of baboon CD4+CD25+ Treg cells for potential use in a non-human primate xenotransplantation model.
31. Third WHO Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials, Changsha, Hunan, China December 12–14, 2018: "The 2018 Changsha Communiqué" The 10‐Year Anniversary of The International Consultation on Xenotransplantation
32. Cardiac xenografts show reduced survival in the absence of transgenic human thrombomodulin expression in donor pigs.
33. CD4+CD25 Hi FoxP3+ regulatory T cells in long-term cardiac xenotransplantation.
34. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.